LakeShore Biopharma Co., Ltd (LSBCF)
OTCMKTS · Delayed Price · Currency is USD
0.8416
+0.0157 (1.90%)
Nov 19, 2025, 4:00 PM EST
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $34.68 million as of November 20, 2025. Its market cap has decreased by -21.98% in one year.
Market Cap
34.68M
Enterprise Value
87.92M
Revenue
84.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.84
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from 227.76M to 34.68M, a decrease of -84.77%. That is a compound annual growth rate of -35.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 34.68M | -47.46% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
| Aug 5, 2021 | 227.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 807.30M |
| Elite Pharmaceuticals | 624.11M |
| Glass House Brands | 451.06M |
| CytoDyn | 396.27M |
| American Oncology Network | 369.77M |
| Northwest Biotherapeutics | 355.00M |
| Silence Therapeutics | 316.47M |
| Nika Pharmaceuticals | 311.89M |